Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
08/06/2003 | CN1433796A Medicine for treating genital herpes and preparation process thereof |
08/06/2003 | CN1433795A Traditional Chinese granule medicine for preventing and caring prawn viral and bacterial disease |
08/06/2003 | CN1433792A Traditional Chinese medicine for treating child pneumonia |
08/06/2003 | CN1433788A Method for extracting effective active component of rodgersia aesculifolia and use thereof |
08/06/2003 | CN1433785A Formula of adhesive plaster for treating painful swelling |
08/06/2003 | CN1433777A Cerium carried (Ôàó) rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof |
08/06/2003 | CN1433765A Sodium foscarnet froozen dry preparation and process for preparing same |
08/06/2003 | CN1433764A Sodium foscarnet gel preparation and preparation process thereof |
08/06/2003 | CN1433763A Enoxacin preparation and preparation process thereof |
08/06/2003 | CN1433758A Use of potassium dehydroandrographolide succinate in preparing external used medicine |
08/06/2003 | CN1433757A Use of potassium dehydroandrographolide succinate in preparing oral cavity local applied medicine for treating plaryngitis |
08/06/2003 | CN1433756A Use of potassium dehydroandrographolide succinate in preparing external used medicine for treating dermatosis |
08/06/2003 | CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic |
08/06/2003 | CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
08/06/2003 | CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections |
08/06/2003 | CN1117095C Antibacterial substituted 7-2cylamino-3(methylhydrazono) methyl-cephalosponins and intermediates |
08/06/2003 | CN1117085C Sparfloxacin salt and synthesis method and use thereof |
08/06/2003 | CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
08/06/2003 | CN1116899C Oral pharmaceutical dosage forms comprising a proton pump inhibitorand NSAID |
08/06/2003 | CN1116890C Medicine for treating hepatitis B |
08/06/2003 | CN1116886C Process for preparing Chinese-medicinal pills containing borneol |
08/05/2003 | US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. |
08/05/2003 | US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
08/05/2003 | US6602999 Preparing a solution of cefpodoxime proxetil in a suitable solvent and recovering amorphous form of cefpodoxime proxetil from said solution by spray drying |
08/05/2003 | US6602991 Solution composed of sodium chloride, monobasic and dibasic sodium phosphate dissolved in water; agitation, filtering and drying; use in the treatment for cholera and as antidote for ferrous ion intoxication |
08/05/2003 | US6602984 Human elastase IV |
08/05/2003 | US6602885 Viricides, organ transplants, antiarthritic agents |
08/05/2003 | US6602882 Quinoline derivatives and their use as antibacterial agents |
08/05/2003 | US6602881 Anti-inflammatory uses of manzamines |
08/05/2003 | US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases |
08/05/2003 | US6602872 Substituted pyridazines having cytokine inhibitory activity |
08/05/2003 | US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds |
08/05/2003 | US6602709 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
08/05/2003 | US6602705 Expression of HIV polypeptides and production of virus-like particles |
08/05/2003 | US6602664 3′-azido-2′,3′-dideoxyuridine in an anti-HIV effectiveness test protocol |
08/05/2003 | US6602525 Compositions comprising nitrofurantoin and uva ursi |
08/05/2003 | US6602519 Peptide factor used as replacement to steroid therapy; neutrophil migration stimulating activity; treating conditions associated with an inflammatory response of septic shock |
08/05/2003 | US6602508 Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine |
08/05/2003 | US6602506 Immunogenic composition; bactericidal |
08/05/2003 | US6602505 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1 |
08/05/2003 | US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions |
08/05/2003 | US6602491 Alkyl hydroxybenzoate in an oral care composition with an alkaline pH |
08/05/2003 | US6602296 Chemical supplementation of bone |
08/01/2003 | CA2370396A1 Hepatitis c inhibitor tri-peptides |
08/01/2003 | CA2369970A1 Hepatitis c inhibitor tri-peptides |
07/31/2003 | WO2003062472A1 Cooperative oligonucleotides |
07/31/2003 | WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
07/31/2003 | WO2003062443A2 Novel substituted alkane compounds and uses thereof |
07/31/2003 | WO2003062424A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
07/31/2003 | WO2003062406A1 Method for the production of resveratrol in cell cultures |
07/31/2003 | WO2003062394A2 Methods and compositions for rna interference |
07/31/2003 | WO2003062276A2 Multimers of receptor-binding ligands |
07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
07/31/2003 | WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
07/31/2003 | WO2003062265A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
07/31/2003 | WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies |
07/31/2003 | WO2003062260A1 Triterpene quaternary salts as biologically active surfactants |
07/31/2003 | WO2003062252A1 Edg receptor agonists |
07/31/2003 | WO2003062242A1 Biocidal compounds and their preparation |
07/31/2003 | WO2003062238A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors |
07/31/2003 | WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
07/31/2003 | WO2003062231A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones |
07/31/2003 | WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
07/31/2003 | WO2003062211A1 Pyrimidinone viral polymerase inhibitors |
07/31/2003 | WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
07/31/2003 | WO2003062204A1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
07/31/2003 | WO2003061767A1 Methods and compositions for the treatment of asthma and related disorders |
07/31/2003 | WO2003061707A1 Dermatological water-resistant compositions with sun screens and method for production and use of such compositions |
07/31/2003 | WO2003061704A2 Combination therapy for the treatment of bacterial infections |
07/31/2003 | WO2003061672A1 Method of treatment of gastrointestinal disease and polymeric composition for use therein |
07/31/2003 | WO2003061671A1 Amido macrolides |
07/31/2003 | WO2003061668A1 Use of pulmonary surfactant for the prevention of infectious diseases |
07/31/2003 | WO2003061667A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
07/31/2003 | WO2003061666A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
07/31/2003 | WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators |
07/31/2003 | WO2003061634A1 Sustained release pharmaceutical composition |
07/31/2003 | WO2003061626A1 Polymeric gel system for the controlled delivery of codrugs |
07/31/2003 | WO2003061620A2 Peptide-carrying bodies for immune response |
07/31/2003 | WO2003061589A2 Methods for treating diseases or conditions with peptide constructs |
07/31/2003 | WO2003061577A2 Polyalkylene glycol with moiety for conjugating biologically active compound |
07/31/2003 | WO2003061560A2 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
07/31/2003 | WO2003061558A2 Glycoconjugate vaccines for use in immune-compromised populations |
07/31/2003 | WO2003061554A2 Composition containing moutan root bark extract as active ingredient |
07/31/2003 | WO2003061389A1 Antiseptic compositions and methods |
07/31/2003 | WO2003047516A3 Pyrimidine compounds |
07/31/2003 | WO2003035679A3 Molecules |
07/31/2003 | WO2003034988A3 Injectable compositions for the controlled delivery of pharmacologically active compound |
07/31/2003 | WO2003032911A3 Anti-angiogenic and cytotoxic fused pyrimidines |
07/31/2003 | WO2003029484A3 Antimicrobial methods and materials |
07/31/2003 | WO2003016333A3 Virus coat protein/receptor chimeras and methods of use |
07/31/2003 | WO2003007995A3 Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone |
07/31/2003 | WO2003006495A3 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
07/31/2003 | WO2003000024A3 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
07/31/2003 | WO2002100408A3 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
07/31/2003 | WO2002064627A3 Crystallization of igf-1 |
07/31/2003 | WO2002060936A3 Vaccine and compositions for the prevention and treatment of neisserial infections |
07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
07/31/2003 | WO2002059148A3 A method for identification, isolation and production of antigens to a specific pathogen |
07/31/2003 | WO2002047730A3 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
07/31/2003 | WO2002036203A3 Azole containing compositions with enhanced antifungal activity |